Cargando…
Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?
The treatment of advanced lung cancer has become increasingly personalized over the past decade as a result of the improved understanding of tumor molecular biology and anti-tumor immunity. An adequate tumor sample is central to targetable mutation analysis, and immunologic profiling. The majority o...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330770/ https://www.ncbi.nlm.nih.gov/pubmed/32642252 http://dx.doi.org/10.21037/jtd-19-4119 |